Medindia

X

Access Pharmaceuticals to Host North American MuGard Commercialization Update Conference Call for Investors

Thursday, July 29, 2010 Drug News J E 4
Advertisement

Contact: Company

Contact: Investor Relations

Christine Berni

Donald C. Weinberger/Diana Bittner (media)

Director of Investor Relations

Wolfe Axelrod Weinberger Assoc. LLC

Access Pharmaceuticals, Inc.

(212) 370-4500

(212) 786-6208

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
WaferGen Announces Purchase of SmartChip Products ...
S
PDI to Present at the BMO Capital Markets 10th Ann...